Business briefs: FDA wants to relax Alzheimer's approvals rules, generics office head quits
FDA intends to loosen the rules for approving new Alzheimer's disease treatments, the agency said in a proposal that ran ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.